| Literature DB >> 23979397 |
Kazuhiro Umeyama1, Kasumi Honda, Hitomi Matsunari, Kazuaki Nakano, Tatsuro Hidaka, Keito Sekiguchi, Hironori Mochizuki, Yasuhiro Takeuchi, Tsukasa Fujiwara, Masahito Watanabe, Masaki Nagaya, Hiroshi Nagashima.
Abstract
Somatic cell nuclear transfer (SCNT) is a useful technique for creating pig strains that model human diseases. However, production of numerous cloned disease model pigs by SCNT for large-scale experiments is impractical due to its complexity and inefficiency. In the present study, we aimed to establish an efficient procedure for proliferating the diabetes model pig carrying the mutant human hepatocyte nuclear factor-1α gene. A founder diabetes transgenic cloned pig was generated by SCNT and treated with insulin to allow for normal growth to maturity, at which point epididymal sperm could be collected for cryopreservation. In vitro fertilization and intrafallopian insemination using the cryopreserved epididymal sperm resulted in diabetes model transgenic offspring. These results suggest that artificial reproductive technology using cryopreserved epididymal sperm could be a practical option for proliferation of genetically modified disease model pigs.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23979397 PMCID: PMC3934148 DOI: 10.1262/jrd.2013-069
Source DB: PubMed Journal: J Reprod Dev ISSN: 0916-8818 Impact factor: 2.214
Biochemical parameters in the plasma of the diabetes model founder transgenic-cloned pig
| Control (n = 10) | Founder | |||||
| Mean ± SD | 4 monthsa | 8 monthsa | 12 monthsa | 13 monthsb | ||
| ALT | (U/l) | 28.2 ± 8.1 | 40.0 | 37.0 | 32.0 | 32.0 |
| AST | (U/l) | 24.8 ± 10.4 | 26.0 | 27.0 | 24.0 | 16.0 |
| TP | (g/dl) | 7.4 ± 0.7 | 6.7 | 6.5 | 6.1 | 6.5 |
| TG | (mg/dl) | 32.7 ± 27.1 | 48.0 | 28.0 | 41.0 | 74.0 |
| T-CHO | (mg/dl) | 70.7 ± 17.9 | 124.0 | 59.0 | 54.0 | 75.0 |
| GLU | (mg/dl) | 109.6 ± 26.1 | 246.0 | 230.0 | 195.0 | 536.0 |
| 1,5-AG | (mg/dl) | 5.1 ± 1.8 | - | 1.2 | 1.1 | 1.0 |
| BUN | (mg/dl) | 9.9 ± 1.8 | 15.6 | 10.1 | 12.8 | 27.1 |
| CRE | (mg/dl) | 1.6 ± 0.5 | 0.8 | 1.5 | 1.4 | 1.5 |
| Na | (mEq/l) | 140.8 ± 2.9 | 136.0 | 134.0 | 143.0 | 135.0 |
| K | (mEq/l) | 4.9 ± 1.3 | 3.8 | 4.4 | 3.4 | 4.3 |
| Cl | (mEq/l) | 101.6 ± 2.4 | 99.0 | 94.0 | 97.0 | 94.0 |
a Treated with insulin. b Not treated with insulin. 1,5-AG, 1,5-anhydroglucitol; AST, aspirate aminotransferase; ALT, alanine aminotransferase; BUN, blood urea nitrogen; Cl, chloride; CRE, creatinine; GLU, glucose; K, potassium; Na, sodium; T-CHO, total cholesterol; TG, triglyceride; TP, total protein.
Efficiency of fertilization and development of porcine oocytes fertilized in vitro with cryopreserved boar sperm
| Type of sperm | Inseminated sperm | No. of oocytes | No. of oocytes | ||||
| Examined after | Fertilized (%) | Normally | Cultured after | Normally | Developed to | ||
| WT | 1.0 | 97 | 53 (54.6)a | 25 (47.2)a | 69 | 42 (60.9)a | 32 (46.4)a |
| DM-8m | 1.0 | 45 | 12 (26.7)b | 10 (83.3) | 37 | 19 (51.4)a | 14 (37.8)a |
| DM-12m | 1.0 | 125 | 30 (24.0)b | 28 (93.3)b | 83 | 23 (27.7)b | 14 (16.9)b |
ab Significant differences (P<0.05).
Determination of optimal sperm concentration for in vitro fertilization of cryopreserved diabetic boar sperm
| Type of sperm | Inseminated sperm | No. of oocytes | No. of oocytes | ||||
| Examined after | Fertilized(%) | Normally | Cultured after | Normally | Developed to | ||
| DM-8m | 1.0 | 45 | 12 (26.7)a | 10 (83.3) | 37 | 19 (51.4) | 14 (37.8) |
| 2.5 | 125 | 86 (68.8)b | 45 (52.3) | 71 | 48 (67.6)a | 41 (57.7) | |
| 5.0 | 129 | 71 (55.0)b | 45 (63.4) | 66 | 31 (47.0)b | 30 (45.5) | |
| DM-12m | 1.0 | 125 | 30 (24.0)a | 28 (93.3) | 83 | 23 (27.7)a | 14 (16.9)a |
| 2.5 | 144 | 60 (41.7)b | 51 (85.0) | 95 | 43 (45.3)b | 33 (34.7)b | |
| 5.0 | 112 | 70 (62.5)c | 58 (82.9) | 67 | 38 (56.7)b | 34 (50.7)b | |
ab, ac, bc Significant differences (P<0.05).
Production of offspring by in vitro fertilization and intrafallopian insemination of cryopreserved diabetic boar sperm
| Methods | Recipients | No. of embryos | No. of live piglets | No. of stillborn piglets | Proportion of tg | Average (mean ± SEM) |
| IVF-1a | P57 | 70 | 11 (4) | 3 (0) | 4/14 (28.6) | 0.56 ± 0.05 |
| P84 | 112 | 7 (2) | 0 (0) | 2/7 (28.6) | 1.09 ± 0.06 | |
| P162 | 93 | 4 (1) | 4 (3) | 4/8 (50.0) | 0.70 ± 0.13 | |
| P58c | 44 | - | - | - | - | |
| IVF-2b | P99 | 20 | 4 (1) | 3 (1) | 2/7 (28.6) | 0.75 ± 0.10 |
| P135 | 15 | 5 (2) | 0 (0) | 2/5 (40.0) | 0.84 ± 0.09 | |
| Intrafallopian insemination | B47 | 10d | 6 (4) | 2 (2) | 6/8 (75.0) | 1.07 ± 0.05 |
| B45c | 10d | - | - | - | - | |
| B46c | 8d | - | - | - | - | |
| B51c | 14d | - | - | - | - |
a Embryos were transferred at the 1–8-cell stage. b Embryos were transferred at the blastocyst stage. c Returned to estrus. d No. of ovulations.